Matthew Baggott
Vorstandsvorsitzender bei Tactogen, Inc.
Profil
Matthew Baggott is the founder and current CEO of Tactogen, Inc. which was founded in 2020.
He is also currently a Venture Partner at Noetic Psychedelic.
Dr. Baggott received his undergraduate degree from The University of Chicago and his doctorate from the University of California, Berkeley.
Aktive Positionen von Matthew Baggott
| Unternehmen | Position | Beginn |
|---|---|---|
Tactogen, Inc.
 Tactogen, Inc. Pharmaceuticals: MajorHealth Technology Tactogen, Inc. develops mental wellness medicines. The American company was founded in 2020 by Matthew Baggott and Luke A. Pustejovsky. Matthew Baggott has been the CEO since 2020. | Vorstandsvorsitzender | 01.01.2020 |
Noetic Psychedelic
 Noetic Psychedelic Investment ManagersFinance Noetic Psychedelic (Noetic) is a venture capital firm, a subsidiary of Grey House Partners GP, Inc. founded in 2019. The firm is headquartered in Toronto, Canada. | Private Equity Investor | - |
Ausbildung von Matthew Baggott
| The University of Chicago | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Tactogen, Inc.
Tactogen, Inc. Pharmaceuticals: MajorHealth Technology Tactogen, Inc. develops mental wellness medicines. The American company was founded in 2020 by Matthew Baggott and Luke A. Pustejovsky. Matthew Baggott has been the CEO since 2020. | Health Technology |
Noetic Psychedelic
Noetic Psychedelic Investment ManagersFinance Noetic Psychedelic (Noetic) is a venture capital firm, a subsidiary of Grey House Partners GP, Inc. founded in 2019. The firm is headquartered in Toronto, Canada. | Finance |